Ramautarsing, Reshmie A <br/><br/>
Neither branded nor generic lopinavir/ritonavir produces adequate lopinavir concentrations at a reduced dose of 200/50 mg twice daily.  [electronic resource] 

 -  Journal of acquired immune deficiency syndromes (1999)  Jan 2012 
 - 55-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1944-7884 
<br/><br/><label>Standard No.: </label>10.1097/QAI.0b013e31823ba736  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-HIV Agents--administration & dosage<br/>Cross-Over Studies<br/>Dose-Response Relationship, Drug<br/>Female<br/>HIV Infections--drug therapy<br/>HIV Protease Inhibitors--administration & dosage<br/>Humans<br/>Lopinavir--administration & dosage<br/>Male<br/>Middle Aged<br/>Ritonavir--administration & dosage<br/>Therapeutic Equivalency